×
About 2,068 results

ALLMedicine™ Dry Skin Center

Research & Reviews  363 results

Lifetime prevalence and determinants of hand eczema in an adolescent population in Germ...
https://doi.org/10.1111/jdv.17814
Journal of the European Academy of Dermatology and Venere... Wang J, Tischer C et. al.

Nov 16th, 2021 - Hand eczema is a common inflammatory skin disorder in both adolescence and adulthood. We sought to assess the lifetime prevalence of hand eczema and associated exogenous and endogenous risk factors among adolescents in Germany. This was a cross-se...

SkIN hydrAtion Evaluation With TeRAhertz Scanning
https://clinicaltrials.gov/ct2/show/NCT05121207

Nov 16th, 2021 - The SINATRA study is pilot study with a primary aim to explore the feasibility of the trial methodology. In addition, secondary objectives of the study will investigate if THz light is able to detect subtle differences in skin hydration and their ...

Natural moisturizing factors in children with and without eczema: Associations with lif...
https://doi.org/10.1111/jdv.17787
Journal of the European Academy of Dermatology and Venere... Basu MN, Mortz CG et. al.

Nov 8th, 2021 - Filaggrin-derived natural moisturizing factors (NMF) play an important role in skin barrier function and in atopic dermatitis (AD). Its deficiency is associated with dry skin and increased surface pH. Studies on childhood environmental exposures a...

Optimal application method of a moisturizer on the basis of skin physiological functions.
https://doi.org/10.1111/jocd.14560
Journal of Cosmetic Dermatology; Ueda Y, Murakami Y et. al.

Nov 8th, 2021 - Clinical studies have clarified the usefulness of moisturizers for dry skin diseases. However, few reports exist on the appropriate application of moisturizers with respect to the skin physiological functions. To clarify the optimal moisturizer ap...

Impaired skin barrier and allergic sensitization in early infancy.
https://doi.org/10.1111/all.15170
Allergy Wärnberg Gerdin S, Lie A et. al.

Nov 6th, 2021 - Factors predicting allergic sensitization in the first 6 months of life are poorly understood. We aimed to determine whether eczema, dry skin, and high transepidermal water loss (TEWL) at 3 months were associated with allergic sensitization at 6 m...

see more →

Guidelines  1 results

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibito...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532717
Drugs Califano R, Tariq N et. al.

Jul 19th, 2015 - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib, erlotinib, and afatinib are standard-of-care for first-line treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). These drugs have a prove...

see more →

Drugs  262 results see all →

Clinicaltrials.gov  23 results

SkIN hydrAtion Evaluation With TeRAhertz Scanning
https://clinicaltrials.gov/ct2/show/NCT05121207

Nov 16th, 2021 - The SINATRA study is pilot study with a primary aim to explore the feasibility of the trial methodology. In addition, secondary objectives of the study will investigate if THz light is able to detect subtle differences in skin hydration and their ...

Development of Adaptive Vacuum Suspension to Improve Prosthetic Fit and Residual Limb Health
https://clinicaltrials.gov/ct2/show/NCT03927404

Oct 6th, 2021 - There are a total of 3 study visits, (some visits may be broken into separate visits per preference of subject), including socket fitting visits (which could be 2 separate visits), a baseline visit, and a final visit. During the socket visit, whic...

Evaluation of Skin Hydration in Adults With Dry Skin Using a Moisturizer With an Added Sterilized Probiotic
https://clinicaltrials.gov/ct2/show/NCT05013645

Aug 19th, 2021 - Double-blind placebo-controlled clinical trial to evaluate the effectiveness of a sterilized probiotic on skin health and hydration in adults with dry skin. The goal of the study is to determine if the addition of a skin-conditioning probiotic to ...

A Randomized, Double-blinded, Placebo Controlled, Monocentric Study to Evaluate the Anti-ageing and Skin Brightening Benefit of the Test Product in Healthy Female Subjects
https://clinicaltrials.gov/ct2/show/NCT04276753

Jun 25th, 2021 - Every day the cells of the outer layer of skin die off, shed, and regenerate. When young, skin cells turn over quickly, but that turnover rate begins to slow with age, beginning as early as twenties. As a result, skin loses its luster and begins t...

The Effect of ESWT in Carpal Tunnel Syndrome
https://clinicaltrials.gov/ct2/show/NCT04896398

May 21st, 2021 - Carpal tunnel syndrome is a clinical picture that occurs with a group of symptoms and signs as a result of compression and compression in the carpal tunnel where the median nerve passes to the wrist. Another name is hand-wrist canal disease, the m...

see more →

News  144 results

FDA OKs First Drug for Most Common Form of Dwarfism
https://www.medpagetoday.com/endocrinology/growthdisorders/95786

Nov 19th, 2021 - The FDA granted accelerated approval to the first drug to spur growth in kids with the most common form of dwarfism, the agency announced on Friday. Vosoritide (Voxzogo), a once-daily injectable treatment, is indicated for children 5 years and old...

Dr. Lacouture On Preventing Dermatological Adverse Events in Melanoma
https://www.onclive.com/view/dr-lacouture-on-preventing-dermatological-adverse-events-in-melanoma

Oct 6th, 2021 - Mario E. Lacouture, MD, a dermatologist with Memorial Sloan Kettering Cancer Center, explains how providers can manage adverse events that result from melanoma therapies. BRAF and MEK inhibitors have numerous common side effects that can some...

Partner Perspectives: Moving Cholangiocarcinoma Into the Age of Targeted Therapy
https://www.onclive.com/view/partner-perspectives-moving-cholangiocarcinoma-into-the-age-of-targeted-therapy

Oct 6th, 2021 - Biliary tract cancers are an aggressive group of malignancies that historically have been very challenging to treat because of their anatomical location and limited responsiveness to systemic therapy.1-3 Biliary cancers arise from the epithelial l...

FDA Greenlights Companion Diagnostic for Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
https://www.onclive.com/view/fda-greenlights-companion-diagnostic-for-mobocertinib-in-egfr-exon-20-insertion-nsclc

Sep 16th, 2021 - The FDA has granted premarket approval to the Oncomine Dx Target Test for use as a companion diagnostic to identify patients with non–small cell lung cancer (NSCLC) whose tumors harbor EGFR exon 20 insertion mutations who may be eligible to receiv...

FDA OK's New Drug for Lung Cancers With Exon 20 Mutations
https://www.medpagetoday.com/hematologyoncology/lungcancer/94539

Sep 16th, 2021 - The FDA granted accelerated approval to mobocertinib (Exkivity) as a second-line treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations, Takeda announced on Wednesday. Approval of...

see more →

Patient Education  34 results see all →